GANXNasdaq

Gain Therapeutics, Inc.

Pharmaceutical Preparations · DE · CIK 1819411

Develops novel small molecule therapeutics for CNS, LSDs, metabolic, and oncology diseases using its Magellan™ platform

$72M

Market cap

$1.98

Last close

+13.1%

+7.0%

12.5M

Volume

Price · last 39 sessions+4.2%

May 4L $1.59 · H $2.02Jun 29

106

Total filings

Jun 29, 2026

Last filing

12/31

Fiscal year end

Similar companies

Comparable business profile · signals at a glance